Literature DB >> 21549875

Late-onset hypogonadism.

Nazem Bassil1.   

Abstract

Late-onset hypogonadism is a clinical and biological syndrome associated with advancing age and characterized by typical symptoms and a deficiency in serum testosterone levels. It is a common condition but often underdiagnosed and undertreated. The main symptoms of hypogonadism are reduced libido/erectile dysfunction, reduced muscle mass and strength, increased adiposity, osteoporosis/low bone mass, depressed mood, and fatigue. Testosterone replacement therapy is only warranted in the presence of both clinical symptoms suggesting hormone deficiency and decreased hormone levels. It improves libido and sexual function, bone density, muscle mass, body composition, mood, erythropoiesis, cognition, quality of life, and cardiovascular disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549875     DOI: 10.1016/j.mcna.2011.03.001

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  16 in total

Review 1.  Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.

Authors:  Jason R Kovac; Jason Kovac; Alexander W Pastuszak; Dolores J Lamb; Larry I Lipshultz
Journal:  Postgrad Med       Date:  2014-11       Impact factor: 3.840

2.  Excessive daytime sleepiness in sleep apnea: any role of testosterone or vitamin D?

Authors:  P Šiarnik; M Jurík; M Hardoňová; K Klobučníková; J Veverka; P Šurda; P Turčáni; B Kollár
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

Review 3.  Current state of practice regarding testosterone supplementation therapy in men with prostate cancer.

Authors:  Jason R Kovac; Michael M Pan; Larry I Lipshultz; Dolores J Lamb
Journal:  Steroids       Date:  2014-07-27       Impact factor: 2.668

4.  Decreased serum testosterone level was not significantly correlated with lipid indices in elderly men.

Authors:  Neda Meftah; Ali Bijani; Seyed Reza Hosseini; Amir Morteza Soleimani
Journal:  Caspian J Intern Med       Date:  2021-03

5.  Effects of testosterone levels on functional recovery with rehabilitation in stroke patients.

Authors:  Ryo Momosaki; Masahiro Abo; Shu Watanabe; Wataru Kakuda; Naoki Yamada; Kenjiro Mochio
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-09-29       Impact factor: 1.742

Review 6.  Musculoskeletal disorders in chronic obstructive pulmonary disease.

Authors:  Nele Cielen; Karen Maes; Ghislaine Gayan-Ramirez
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

Review 7.  Could androgens maintain specific domains of mental health in aging men by preserving hippocampal neurogenesis?

Authors:  Mark I Ransome
Journal:  Neural Regen Res       Date:  2012-10-05       Impact factor: 5.135

8.  The correlation between emotional distress and aging males' symptoms at a psychiatric outpatient clinic: sexual dysfunction as a distinguishing characteristic between andropause and anxiety/depression in aging men.

Authors:  Ching-Yen Chen; Chin-Pang Lee; Yu Chen; Jun-Ran Jiang; Chun-Lin Chu; Chun-Liang Chen
Journal:  Clin Interv Aging       Date:  2013-06-04       Impact factor: 4.458

9.  Asexuality development among middle aged and older men.

Authors:  Yan-Ping Huang; Bin Chen; Ping Ping; Hong-Xiang Wang; Kai Hu; Hao Yang; Tao Zhang; Tan Feng; Yan Jin; Yin-Fa Han; Yi-Xin Wang; Yi-Ran Huang
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 10.  Andropause: Current concepts.

Authors:  Parminder Singh
Journal:  Indian J Endocrinol Metab       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.